The "Wearable Injectors - Market Insights, Competitive Landscape, and Market Forecast - 2027" report has been added to ResearchAndMarkets.com's offering.

The global wearable injectors market was valued at USD 6,725.58 million in 2021, growing at a CAGR of 12.78% during the forecast period from 2022 to 2027 to reach USD 13,815.56 million by 2027.

The wearable injectors market is indorsing optimistic growth primarily owing to the increasing incidences of chronic conditions such as cancer, diabetes, and cardiovascular disorders among others.

Further, rising concern over the hazards and limitations related to needle sticks, rising need & demand for patient compliance to treatment, and rising innovations & technological advancement in the device will create a requisite for wearable injectors in the market.

In addition, the increasing product launches and approvals, and the rising reimbursement scenarios across the globe will further upsurge the overall growth of the wearable injectors market. Therefore, the market for wearable injectors is estimated to grow at a significant CAGR during the forecast period from 2022 to 2027.

Wearable Injectors Market Dynamics:

According to World Health Organization (WHO) 2022 factsheet, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The new cases of breast cancer in 2020 was 2.26 million, followed by lung cancer with 2.21 million cases, colon and rectum cancer reported 1.93 million news cases, prostate cancer 1.41 million cases, skin cancer - 1.20 million cases and stomach cancer 1.09 million cases, worldwide.

As per the 10th Edition of the International Diabetes Federation 2021, nearly 537 million adults (20-79 years) were living with diabetes. This number is predicted to rise to 643 million by 2030 and 783 million by 2045.

Thus, the increasing prevalence of chronic diseases will, leads to an increase in demand for wearable injectors as the injectors are used for administering various drugs over an extended period to patients suffering from chronic diseases. Cardiovascular diseases are considered to be the leading cause of death globally.

As per the World Health Organization in the year 2021, an estimated 17.9 million people died from cardiovascular disorders in 2019, illustrating 32% of all global deaths. Out of the 17 million premature deaths (under the age of 70 years) due to non-communicable diseases in 2019, 38% of the deaths were caused due to cardiovascular disorders.

Wearable Injectors Market Segment Analysis:

Wearable Injectors Market by Type (On-Body Injectors and Off-Body Injectors), Indication (Oncology, Autoimmune Disease, Diabetes, Cardiovascular Disease, and Others), End-User (Hospitals & Clinics, Home Care, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the therapy segment of the wearable injectors market, the oncology segment tends to hold a significant revenue share in the year 2021. This was primarily owing to the rising incidences of various cancers across the globe.

For instance, according to a 2021 update by the World Health Organization (WHO), the new cancer cases in 2020 were breast cancer with 2.26 million cases, lung cancer is the second most common cancer type with 2.21 million cases followed by colon and rectum cancer with 1.93 million cases, prostate cancer with 1.41 million cases, skin (non-melanoma) cancer with 1.20 million cases, and stomach cancer with 1.09 million cases.

North America is expected to dominate the overall Wearable Injectors Market:

Among all the regions, North America is expected to dominate the global wearable injectors market in the year 2021 and is expected to do the same during the forecast period from 2022-2027.

This domination is attributed to the rising prevalence of chronic diseases & lifestyle-related diseases, the presence of sophisticated healthcare infrastructure, presence of key players in the region, among others are the key factors contributing to the wearable injectors market growth in the country and is expected to aid in the growth of the North America wearable injectors devices market.

Wearable Injectors Market Key Players:

Some of the key market players operating in the wearable injectors market include BD, Ypsomed, Amgen Inc., West Pharmaceutical Services, Inc., Stevanato Group, Eitan Medical, United Therapeutic Corporation, Buhler Motor GmbH, Sonceboz, Subcuject Aps, Nemera, SHL Medical AG, Gerresheimer AG, Insulet Corporation, CeQur SA, and others.

Key Takeaways from the Wearable Injectors Market Report Study

• Market size analysis for the current wearable injectors market (2021), and market forecast for 5 years (2022-2027)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the wearable injectors market
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the global wearable injectors market
• Various opportunities are available for the other competitor in the wearable injectors market space
• What are the top-performing segments in 2021? How these segments will perform in 2027.
• Which are the top-performing regions and countries in the current wearable injector's market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for wearable injector's market growth in the coming future?

For more information about this report visit https://www.researchandmarkets.com/r/5rh2m0

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230323005433/en/